Ixekizumab shortage status
1 active shortage notice across 1 country.
Last updated 2 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Ixekizumab
- Brand names
- Taltz
- Class
- Auto-created by Agenzia Italiana del Farmaco — Carenze scraper
Where Ixekizumab is in shortage
Why Ixekizumab is in shortage
- product discontinuation — e.g. “Product discontinued / no longer available on the Australian market.” (Australia)
Recent shortage history
- Italy: resolved 27 Jul 2020 (began 27 Jul 2020)
- Italy: resolved 12 Nov 2019 (began 12 Nov 2019)
Frequently asked questions
Is Ixekizumab currently in shortage?
Yes. As of the latest regulator updates, Ixekizumab has 1 active shortage notice across 1 country (Australia). Status is refreshed daily from official regulatory sources.
Why is Ixekizumab in shortage?
Regulators attribute the current Ixekizumab shortages to product discontinuation. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Ixekizumab shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Ixekizumab status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.